- New medical treatments for glaucoma where others have failed
- World Retina Week 2022
- Scientists join forces to attack Usher's Syndrom
New biomarker discovered that helps determine severity of glaucoma
- And, about ten more articles about the science and medicine around blindness this week
Editorial By Chris Hofstader
As I did yesterday with the World Blind Herald News Digest, I'm posting the WBH Science Digest a bit later than usual today. I am on vacation in my favorite fishing village on Earth and just got back to my hotel after fishing all day with my favorite fishing guide and having caught a ton of really terrific fish.
Thus, I'm rushing through the editorial as I want to get this published and to take a nap (I'm not as young as I used to be).
I had planned on moving the "Preventing Blindness" section from the news digest over here to the science page but I'm going to push that off into next week.
Thanks for visiting the site and for reading the digest.
Science and Medicine
Blind and partially sighted people are particularly vulnerable during the cost of living crisis, charities have warned. This story comes to us from: Association of Optometrists.
I have a Florida medical marijuana card and I think marijuana helps me with a couple of health issues. At the same time, I say "I think" the weed helps because the scientific studies cited in this article are almost all incredibly flimsy and this article is far more about sensationalizing the potential health benefits of marijuana than it is about real science.
marijuana will be a better alternative treatment for about 70 types of diseases, including autism, epilepsy, depression, Parkinson’s, glaucoma and other non-cancerous diseases, said medical experts. They noted that multiple studies have shown the effectiveness of medical marijuana in treating illnesses, especially those relating to mental health, as well as alleviating a patient’s pain. This story comes to us from: The Sun Daily.
Phosphoenix aims to enable blind people to regain functional vision, even after extensive damage to the eye or optic nerve. This story comes to us from: Silicon Canals.
XEN® 63 Gel Implant available now for patients with primary open angle glaucoma where previous medical treatments have failed
Glaucoma affects more than 728,000 Canadians. It is one of the leading causes of preventable blindness. Anyone can develop glaucoma but there are several different factors that can increase your risk of developing the disease. This story comes to us from: Yahoo Finance.
A commercial stage biotechnology acceleration development company, is pleased to announce receipt of a European Certificate of Grant for GDF15, a diagnostic marker for determining the severity of glaucoma using the expression levels of Growth Differentiation Factor 15 (GDF15) licensed from the Washington University in St. Louis. Determining the severity of glaucoma. This story comes to us from: Yahoo Finance.
Scientists at the Lions Eye Institute and Ear Science Institute Australia are one step closer to developing personalised therapies for Usher syndrome, the most common form of inherited deaf-blindness, thanks to a prestigious Medical Research Future Fund (MRFF) grant. Lead chief investigator Dr Samuel McLenachan, who runs the Ocular Tissue Engineering Laboratory at the Lions Eye Institute, said the grant will enable the State’s leading experts in eye and ear clinical care and research to coordinate their investigations. This story comes to us from: Mirage News.
… Eye disease that affects the vessels in the retina of premature infants and is the leading cause of visual impairment and blindness in children. This story comes to us from: Medical Dialogues.
NCCVEH Names Dr. Donny W. Suh, Gavin Herbert Eye Institute, UC Irvine, as Recipient of the 8th Annual Bonnie Strickland Champion for Children's Vision Award
The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has announced the recipient of the eighth annual "Bonnie Strickland Champion for Children's Vision Award" as Donny W. Suh, MD, FAAP, MBA, FACS, Chief of Pediatric Ophthalmology and Strabismus, and Professor, Department of Ophthalmology and Visual Science. This story comes to us from: Yahoo Finance.
Opus Genetics Expands Board of Directors with Appointment of Global Ophthalmology Leader Dr. Adrienne Graves
Opus Genetics, a patient-first gene therapy company developing treatments for inherited retinal diseases, today announced the appointment of Adrienne Graves, Ph.D., to its board of directors. Dr. Graves is the former CEO of Santen Inc., where she was responsible for growing the company’s global presence and advancing multiple ophthalmic products through development to approval and commercialization. This story comes to us from: Yahoo Finance.
Retinal problems can cause difficulty in vision and blindness in severe cases. Observing the World Retina Week 2022, eye experts raise awareness about symptoms of damaged retina. This story comes to us from: TheHealthSite.com.
In the worst case, the infection can cause blindness. It is therefore crucial to diagnose and treat the infection as soon as possible. This story comes to us from: Mirage News.